弘毅文化集團(00419.HK)與ESOP及自然人SPV訂立合資平臺股權轉讓文件
格隆匯4月1日丨弘毅文化集團(00419.HK)公告,就獴哥健康業務而言,獴哥集團已剝離其疫苗和體檢業務,終止其私域電商業務,並專注於運營健康消費業務, 而VIE 合約安排項下的VIE結構將不再屬必要。
公司已於2025年4月1日與ESOP及自然人SPV訂立合資平臺股權轉讓文件,旨在收購彼等合共持有合資平臺的40%股權,令合資平臺及其附屬公司成爲集團的全資附屬公司。於2025年4月1日,WFOE與中國股權擁有人分別訂立OPCO股權轉讓協議A及OPCO股權轉讓協議B,供彼等向WFOE轉讓各自於OPCO持有的60%及40%股權;WFOE及OPCO亦就終止VIE合約安排與中國股權擁有人訂立終止協議。訂立該等交易的目的乃爲解散根據合資框架協議及 VIE合約安排就 獴哥健康業務搭建的VIE結構。
根據股權轉讓協議,集團能夠按名義對價取得獴哥集團少數股東所持部分股權的所有權,令公司全資擁有獴哥集團(連同其營運業務)。如此精簡獴哥集團的企業架構將令集團自主且全面掌控獴哥集團及獴哥健康業務的未來企業與業務發展,並悉數享有其所產生的經濟效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.